Association of mutation, copy number alteration, and subtype markers with pathways
Glioblastoma Multiforme (Primary solid tumor)
21 April 2013  |  analyses__2013_04_21
Maintainer Information
Citation Information
Maintained by Spring Yingchun Liu (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Glioblastoma Multiforme (Primary solid tumor cohort) - 21 April 2013: Association of mutation, copy number alteration, and subtype markers with pathways. Broad Institute of MIT and Harvard. doi:10.7908/C1K0726H
- Overview
+ Introduction
- Summary

There are 66 genes with significant mutation (Q value <= 0.1) and 184 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :

21 pathways significantly enriched with genes with copy number alteration or mutation.

36 pathways significantly enriched with marker genes of gene expression subtype 1

62 pathways significantly enriched with marker genes of gene expression subtype 2

16 pathways significantly enriched with marker genes of gene expression subtype 3

- Results
+ The top five pathways enriched with genes with copy number alteration or mutation
+ The top five pathways enriched with marker genes of gene expression subtype 1
+ The top five pathways enriched with marker genes of gene expression subtype 2
+ The top five pathways enriched with marker genes of gene expression subtype 3
+ Methods & Data